American International Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15,143
| Closed | -$42K | – | 3353 |
|
|
2022
Q1 | $42K | Sell |
15,143
-1,067
| -7% | -$2.96K | ﹤0.01% | 2905 |
|
|
2021
Q4 | $76K | Sell |
16,210
-485
| -3% | -$2.27K | ﹤0.01% | 2831 |
|
|
2021
Q3 | $142K | Sell |
16,695
-397
| -2% | -$3.38K | ﹤0.01% | 2627 |
|
|
2021
Q2 | $280 | Buy |
17,092
+222
| +1% | +$4 | ﹤0.01% | 2295 |
|
|
2021
Q1 | $372 | Buy |
16,870
+2,102
| +14% | +$46 | ﹤0.01% | 2006 |
|
|
2020
Q4 | $457 | Sell |
14,768
-423
| -3% | -$13 | ﹤0.01% | 1811 |
|
|
2020
Q3 | $309K | Buy |
15,191
+5,229
| +52% | +$106K | ﹤0.01% | 1862 |
|
|
2020
Q2 | $153K | Buy |
9,962
+3,028
| +44% | +$46.5K | ﹤0.01% | 2285 |
|
|
2020
Q1 | $54K | Sell |
6,934
-401
| -5% | -$3.12K | ﹤0.01% | 2649 |
|
|
2019
Q4 | $105K | Sell |
7,335
-62
| -0.8% | -$888 | ﹤0.01% | 2600 |
|
|
2019
Q3 | $111K | Buy |
7,397
+6,268
| +555% | +$94.1K | ﹤0.01% | 2546 |
|
|
2019
Q2 | $16K | Buy |
+1,129
| New | +$16K | ﹤0.01% | 3068 |
|